MDxHealth (MDXH) Gross Profit (2021 - 2026)

MDxHealth has disclosed Gross Profit across 6 years of filings, most recently posting $16.6 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $16.6 million, up 7.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.7 million (up 20.76% YoY), and the FY2025 annual result was $69.6 million, up 26.28% from the prior year.
• Gross Profit came in at $16.6 million for Q1 2026 at MDxHealth, down from $18.7 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $18.7 million in Q4 2025 to a low of -$2.8 million in Q2 2022.
• The 5-year median for Gross Profit is $12.7 million (2023), against an average of $11.7 million.
• Across the five-year window, Gross Profit jumped 452.1% in 2023 and grew 7.16% in 2026, its largest moves.
• MDxHealth's Gross Profit stood at $7.2 million in 2022, then soared by 75.4% to $12.7 million in 2023, then gained by 22.46% to $15.5 million in 2024, then rose by 20.43% to $18.7 million in 2025, then decreased by 11.09% to $16.6 million in 2026.
• The last three Gross Profit figures came in at $16.6 million (Q1 2026), $18.7 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.